Product Comparison


 
Sanofi Pasteur 49281063315
Sanofi Pasteur 49281012065
McKesson # 1154839 1154838
Description Fluzone® Quadrivalent 2020 - 2021 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Multiple Dose Vial 5 mL Fluzone® High-Dose 2020 - 2021 Flu Vaccine 180 mcg / 0.7 mL Indicated For People 65 Years of Age and Above Prefilled Syringe 0.7 mL
Manufacturer # 4928106331549281012065
Brand Fluzone® Quadrivalent 2020 - 2021Fluzone® High-Dose 2020 - 2021
Manufacturer Sanofi PasteurSanofi Pasteur
Invoice FLUZONE 2020 QUAD, MDV 5ML (10DOSE/VL)FLUZONE 2020, HIGH DOSE QUAD SYR 0.7ML (10DOSE/BX)
    Log In to Order   Log In to Order

Comparison

Container Type Multiple Dose VialPrefilled Syringe
NDC Number 49281-0633-1549281-0120-65
Strength 60 mcg / 0.5 mL180 mcg / 0.7 mL
User Indicated For People 6 Months of Age and AboveIndicated For People 65 Years of Age and Above
Volume 5 mL0.7 mL
Application Flu VaccineFlu Vaccine
Country of Origin United StatesUnited States
Dosage Form InjectionInjection
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires Refrigeration
Type IntramuscularIntramuscular
UNSPSC Code 5120160851201608
Features and Benefits
  • Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Multi-dose vial, 5 mL, for persons 6 months of age and older
  • Fluzone Quadrivalent (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs
  • Fluzone Quadrivalent is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following four influenza strains recommended for the 2020 - 2021 influenza season: A/Michigan/45/2015 X-275 (H1N1), A/Hong Kong/4801/2014 X-263B (H3N2), B/Phuket/3073/2013 (B Yamagata lineage), and B/Brisbane/60/2008 (B Victoria lineage)
  • The 5 mL multi-dose vial presentation contains thimerosal, a mercury derivative, added as a preservative
  • Each 0.5 mL dose from the multi-dose vial contains 25 mcg mercury
  • Each 0.25 mL dose from the multi-dose vial contains 12.5 mcg mercury
  • 6 to 35 months 0.25 mL ; 3 years and above 0.5 mL
  • Fluzone High-Dose is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B virus contained in the vaccine
  • Fluzone High-Dose is indicated for active immunization in persons 65 years of age and older
  • Fluzone High-Dose is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following three influenza strains recommended for the 2020 - 2021 influenza season: A/Brisbane/02/2018 IVR-190 (H1N1), A/Kansas/14/2017 X-327 (H3N2), and B/Maryland/15/2016 BX-69A (a B/Colorado/6/2017-like virus, B Victoria lineage).